A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versus Placebo in Subjects with High Risk Invasive Urothelial Carcinoma
| Title | A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versus Placebo in Subjects with High Risk Invasive Urothelial Carcinoma |
|---|---|
| Description | The study will submit its CSR data to Health Authority of some areas and foreign countries. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA013377 |
| Release Date | 2022-12-31 |
| Submitter | Dingwei Ye (fuscc2012@163.com) |
| Organization | Fudan University Shanghai Cancer Center |
| Submission Date | 2022-11-21 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002405-01 | CA209-274 Backup Dataset | 103 | Biomarker Data | 5.2 MB | zip | 0 | Controlled |